Chapter 2400 — Biotechnology
Ninth Edition, Revision 01.2024
Contents
- 2401 Introduction
- 2402 The Deposit Rules
- 2403 Deposit of Biological Material
- 2404 Need or Opportunity to Make a Deposit
- 2405 Acceptable Depository
- 2406 Time of Making an Original Deposit
- 2407 Replacement or Supplement of Deposit
- 2408 Term of Deposit
- 2409 Viability of Deposit
- 2410 Furnishing of Samples
- 2411 Examination Procedures
- 2412 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format
- 2412.01 Overview of the Sequence Rules
- 2412.02 Definition of “Sequence Listing XML”
- 2412.03 Nucleotides and Amino Acids Included and Excluded From a “Sequence Listing XML”
- 2412.04 Use of Sequence Identifiers to Denote Sequences Disclosed in the Description, Drawings or Claims
- 2412.05 Representation and Symbols for Nucleotide and/or Amino Acid Sequences
- 2412.06 The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2412.07 Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
- 2413 Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
- 2414 Notification of a Failure to Comply with Sequence Listing Requirements and Amendments Relating to “Sequence Listing XML” Files Under 37 CFR 1.835
- 2414.01 Issuance of a Notice Relating to the Requirements For Patent Applications Containing Nucleotide and/or Amino Acid Sequence Disclosures
- 2414.02 Amendment to Add an Initial “Sequence Listing XML” under 37 CFR 1.835(a)
- 2414.03 Amendment Adding to, Deleting from, or Replacing Sequence Information in a “Sequence Listing XML” under 37 CFR 1.835(b)
- 2414.04 Translation of “Sequence Listing XML” is Not an Amended “Sequence Listing XML” under 37 CFR 1.835(b)
- 2414.05 Notifications for Failure to Submit a “Sequence Listing XML” in an International Application under the PCT to be Searched by the United States International Searching Authority or Examined by International Preliminary Examination Authority
- 2414.06 Amendment of a “Sequence Listing XML” in a Patent
- 2415 Applicability date of “Sequence Listing XML” Requirements to Applications Based on Filing Date of Application and Procedures for Failure to Submit Correct Format of Sequence Listing
- 2416 Form Paragraphs
- 2417 Helpful Hints for Sequence Rules Compliance under WIPO Standard ST.26
- 2418 WIPO Sequence Tool
- 2419 Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
- 2419.01 Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
- 2419.02 Patent Grants and Patent Application Publications Containing a Lengthy “Sequence Listing XML”
- 2419.03 Patent Grants and Patent Application Publications Containing a “Sequence Listing XML” of 1GB or Larger
- 2420 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules
- 2421 Overview of the Sequence Rules under WIPO ST.25
- 2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
- 2422.01 Nucleotide and/or Amino Acids Disclosures Requiring a “Sequence Listing”
- 2422.02 The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2422.03 Sequence Listing Submission
- 2422.04 The Requirement for a Computer Readable Copy of the “Sequence Listing”
- 2422.05 [Reserved]
- 2422.06 Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form
- 2422.07 Requirements for Compliance and Consequences of Non-Compliance
- 2422.08 Presumptions Regarding Compliance
- 2422.09 [Reserved]
- 2423 Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data for WIPO ST.25
- 2424 Requirements for Content of a “Sequence Listing” Part of the Specification under WIPO ST.25.
- 2425 Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25
- 2426 Amendments to Add or Replace a “Sequence Listing” and CRF Copy Thereof Subject to WIPO ST. 25
- 2427 Form Paragraphs for Applications Subject to WIPO ST.25
- 2428 Sample Statements under WIPO ST.25
- 2429 Helpful Hints for Sequence Rules Compliance under WIPO ST.25
- 2430 PatentIn Information
- 2431 Sample “Sequence Listing” under WIPO ST.25
- 2432 [Reserved]
- 2433 Box Sequence; Hand Delivery of a “Sequence Listing” and Computer Readable Forms
- 2434 Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
- 2435 Publishing of Patents and Patent Application Publications with a Lengthy “Sequence Listing”